What is the mortality of Juvenile Dermatomyositis (JDM) in the modern treatment era
نویسندگان
چکیده
Background Despite modern treatment approaches Juvenile Dermatomyositis (JDM) remains a serious and potentially life threatening disease. There are few studies which have documented mortality among large series of cases of JDM treated with modern therapeutic approaches. The Juvenile Dermatomyositis National Registry and Repository, UK and Ireland (JDRR) was established in 2000 to facilitate research and improve knowledge about JDM.
منابع مشابه
Treatment approaches to juvenile dermatomyositis (JDM) across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey.
OBJECTIVE There are a number of different approaches to the initial treatment of juvenile dermatomyositis (JDM). We assessed the therapeutic approaches of North American pediatric rheumatologists to inform future studies of therapy in JDM. METHODS A survey describing clinical cases of JDM was sent to pediatric rheumatologists. The cases described children with varying severity of typical dise...
متن کاملCharacteristics and outcome of children with juvenile dermatomyositis in Cape Town: a cross-sectional study
BACKGROUND Juvenile dermatomyositis (JDM) is a rare idiopathic inflammatory childhood myopathy of uncertain aetiology. The demographic and clinical presentation of JDM may differ by race and geographic regions. Few studies have described the characteristics of JDM patients from Africa. METHODS We conducted a retrospective observational study to determine clinical characteristics and outcomes ...
متن کاملAn update in the diagnosis and management of juvenile dermatomyositis
Idiopathic inflammatory myopathies (IIM) represent a group of autoimmune muscle conditions with variable organ involvement amongst the different types [1]. Juvenile dermatomyositis (JDM) is the most prevalent subgroup among children (accounting for up to 85% of cases), while polymyositis, inclusion body myositis and dermatomyositis are most common in adults [2]. JDM is primarily a capillary vas...
متن کاملTreatment and clinical outcome of juvenile dermatomyositis.
Autoimmune diseases in pediatric patients are heterogeneous, including systemic lupus erythematosus, juvenile rheumatoid arthritis, and juvenile dermatomyositis (JDM). JDM is a rare autoimmune disease involving multiple body systems and accounts for 85% of idiopathic inflammatory myopathies in children. JDM may lead to death or long-term disability; therefore, investigations into the important ...
متن کاملRecurrence of juvenile dermatomyositis 8 years after remission
CDASI: Cutaneous Dermatomyositis Area and Severity Index JDM: juvenile dermatomyositis MTX: methotrexate mPSL: methylprednisolone PSL: prednisolone INTRODUCTION Juvenile dermatomyositis (JDM) is a chronic inflammatory disease characterized by typical skin lesions and muscle weakness, which occurs in children and adolescents younger than 16 years. JDM is classified into 3 clinical types accordin...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 6 شماره
صفحات -
تاریخ انتشار 2008